Company research / RYTM
Rhythm Pharmaceuticals, Inc. (RYTM)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Rhythm Pharmaceuticals, Inc. reported revenue of $189.76M. Revenue grew 45.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $239.92M.
Key ratios (year ended 2025-12-31)
89.7%
Gross margin (computed)
-101.2%
Operating margin
-103.6%
Net margin
-141.3%
Return on year-end equity
45.8%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.